{"product_id":"international-myeloma-society-6th-immune-effector-cell-therapies-in-multiple-myeloma-workshop-2025","title":"International Myeloma Society 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop 2025","description":"\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003cdiv class=\"group-target-audience field-group-div\"\u003e\n\u003ch3\u003eInternational Myeloma Society 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop 2025\u003c\/h3\u003e\n\u003cstrong\u003e Include: 9 videos + 1 pdf, size: 9.91 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: hematologists, oncologists treating multiple myeloma\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp data-end=\"615\" data-start=\"255\"\u003eThe 6th Immune Effector Cell Therapies in Multiple Myeloma Workshop is an advanced two-day educational event dedicated to the latest innovations in immune-based treatments for multiple myeloma. This workshop delivers in-depth scientific updates alongside practical, case-driven discussions to help participants optimize clinical outcomes.\u003c\/p\u003e\n\u003cp data-end=\"642\" data-start=\"617\"\u003e\u003cstrong data-end=\"640\" data-start=\"617\"\u003eWhat You Will Learn\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1185\" data-start=\"643\"\u003e\n\u003cli data-end=\"723\" data-start=\"643\"\u003e\n\u003cp data-end=\"723\" data-start=\"645\"\u003eLatest clinical trial data on CAR T-cell therapies targeting BCMA and GPRC5D\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"842\" data-start=\"724\"\u003e\n\u003cp data-end=\"842\" data-start=\"726\"\u003eAdvances in bispecific antibodies and T-cell engagers, including teclistamab, elranatamab, talquetamab, and others\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"958\" data-start=\"843\"\u003e\n\u003cp data-end=\"958\" data-start=\"845\"\u003eStrategies to manage toxicities such as cytokine release syndrome, cytopenias, and organ-specific complications\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1065\" data-start=\"959\"\u003e\n\u003cp data-end=\"1065\" data-start=\"961\"\u003eEmerging therapies: allogeneic CAR T, CAR-NK cells, dual antigen targeting, and trispecific antibodies\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1185\" data-start=\"1066\"\u003e\n\u003cp data-end=\"1185\" data-start=\"1068\"\u003eApproaches to overcome resistance and enhance treatment response through combination regimens and immune modulation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1206\" data-start=\"1187\"\u003e\u003cstrong data-end=\"1204\" data-start=\"1187\"\u003eEvent Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"1400\" data-start=\"1207\"\u003e\n\u003cli data-end=\"1239\" data-start=\"1207\"\u003e\n\u003cp data-end=\"1239\" data-start=\"1209\"\u003e\u003cstrong data-end=\"1219\" data-start=\"1209\"\u003eDates:\u003c\/strong\u003e March 28–29, 2025\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1307\" data-start=\"1240\"\u003e\n\u003cp data-end=\"1307\" data-start=\"1242\"\u003e\u003cstrong data-end=\"1255\" data-start=\"1242\"\u003eLocation:\u003c\/strong\u003e Boston Marriott Long Wharf, Boston, Massachusetts\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1455\" data-start=\"1402\"\u003e\u003cstrong data-end=\"1423\" data-start=\"1402\"\u003eWho Should Attend\u003c\/strong\u003e\u003cbr\u003eThis workshop is ideal for:\u003c\/p\u003e\n\u003cul data-end=\"1782\" data-start=\"1456\"\u003e\n\u003cli data-end=\"1515\" data-start=\"1456\"\u003e\n\u003cp data-end=\"1515\" data-start=\"1458\"\u003eHematologists and oncologists treating multiple myeloma\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1582\" data-start=\"1516\"\u003e\n\u003cp data-end=\"1582\" data-start=\"1518\"\u003eClinical researchers and trial investigators in immune therapy\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1676\" data-start=\"1583\"\u003e\n\u003cp data-end=\"1676\" data-start=\"1585\"\u003eAdvanced practice providers and pharmacists involved in immune effector cell therapy care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1782\" data-start=\"1677\"\u003e\n\u003cp data-end=\"1782\" data-start=\"1679\"\u003eIndustry professionals and academic experts interested in translating research into clinical practice\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"1800\" data-start=\"1784\"\u003e\u003cstrong data-end=\"1798\" data-start=\"1784\"\u003eWhy Attend\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-end=\"2116\" data-start=\"1801\"\u003e\n\u003cli data-end=\"1890\" data-start=\"1801\"\u003e\n\u003cp data-end=\"1890\" data-start=\"1803\"\u003eGain comprehensive insights into the latest immune effector cell therapy developments\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"1971\" data-start=\"1891\"\u003e\n\u003cp data-end=\"1971\" data-start=\"1893\"\u003eLearn practical management strategies for complex therapy-related toxicities\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2047\" data-start=\"1972\"\u003e\n\u003cp data-end=\"2047\" data-start=\"1974\"\u003eNetwork with global leaders and peers in the myeloma research community\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2116\" data-start=\"2048\"\u003e\n\u003cp data-end=\"2116\" data-start=\"2050\"\u003eApply cutting-edge scientific knowledge directly to patient care\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eIEC2025Program.pdf\u003cbr\u003eSESSION 1 CLINICAL UPDATES ON CAR T CELLS.mp4\u003cbr\u003eSESSION 2 CLINICAL UPDATES ON BISPECIFIC ABS TCE’S.mp4\u003cbr\u003eSESSION 3 PRACTICAL CONSIDERATIONS FOR IMMUNE THERAPY.mp4\u003cbr\u003eSESSION 4 NOVEL APPROACHES IN THE CLINIC.mp4\u003cbr\u003eSESSION 5 MANAGING TOXICITIES OF T CELL ENGAGING THERAPIES.mp4\u003cbr\u003eSESSION 6 CORRELATES OF RESPONSE AND RESISTANCE.mp4\u003cbr\u003eSESSION 7 STRATEGIES TO IMPROVE IMMUNE EFFECTOR CELL THERAPIES.mp4\u003cbr\u003eSESSION 8 KEY QUESTIONS IN IMMUNE THERAPY.mp4\u003cbr\u003eWORKSHOP ON SECONDARY MALIGNANCIES AND NON-RELAPSE MORTALITY.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954497065058,"sku":"MED-AMB04628","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/International-Myeloma-Society-6th-Immune-Effector-Cell-Therapies-in-Multiple-Myeloma-Workshop-2025.jpg?v=1779378069","url":"https:\/\/meducourse.com\/products\/international-myeloma-society-6th-immune-effector-cell-therapies-in-multiple-myeloma-workshop-2025","provider":"Meducourse","version":"1.0","type":"link"}